Abeona Therapeutics Inc (ABEO)
Who owns Abeona Therapeutics Inc (ABEO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 64.0% of the shares are freely tradable; institutional investors hold 70.5%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 8.80 | 5,013,052 | +1.0 | 03/31/2026 |
| BlackRock Inc | 5.61 | 3,195,530 | +1.1 | 03/31/2026 |
| AIGH Capital Management, LLC | 5.44 | 3,100,000 | +55.0 | 03/31/2026 |
| Vanguard Group Inc | 4.84 | 2,757,143 | +5.9 | 12/31/2025 |
| Suvretta Capital Management, LLC | 4.70 | 2,676,000 | +0.0 | 03/31/2026 |
| Cable Car Capital LLC | 4.39 | 2,500,000 | +316.7 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.80 | 2,164,851 | +0.0 | 03/31/2026 |
| Kennedy Capital Management Inc | 2.22 | 1,263,511 | +20.3 | 03/31/2026 |
| Geode Capital Management, LLC | 2.12 | 1,209,797 | +6.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.68 | 1,529,026 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Jul 2026 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,478 | 6.53 | 9,651 |
| 9. Jul 2026 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 24,880 | 6.96 | 173,257 |
| 9. Jul 2026 | Seshadri Vishwas | Chief Executive Officer | Sell | 67,971 | 6.96 | 473,330 |
| 9. Jul 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 12,050 | 6.96 | 83,913 |
| 9. Jul 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,606 | 6.96 | 87,784 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.